Purchase Alpha-PVP
Discount program, second-order - 5%OFF, third-order - 7% OFF
With us securely! - re-shipment guarantees.
We always offer new legal products of impeccable quality.
Please make sure that the product is legal in your country and not under control before ordering.
We do not sell pharmaceutical products or controlled products.
Where to buy Alpha-PVP for sale
α-Pyrrolidinopentiophenone, also known as α-pyrrolidinovalerophenone, α-PVP, O-2387, β-keto-prolintane, prolintanone, or desmethyl pyrovalerone, is a synthetic stimulant drug that belongs to the cathinone class of drugs. This substance was created in the 1960s, and its use as a designer drug has been widespread. Commonly, the name "flakka" refers to α-PVP, which is chemically linked to pyrovalerone and is the ketone analogue of prolintane.
History of α-Pyrrolidinopentiophenone
In the 1960s, α-Pyrrolidinopentiophenone was initially produced as part of the cathinone pharmacological class research. Initially, it was used as a medicinal medicine to treat various medical disorders, including attention deficit hyperactivity disorder (ADHD) and narcolepsy. Due to its significant potential for addiction and severe side effects, the medicine was finally discontinued. In recent years, α-PVP has gained popularity as a designer drug with psychotropic and stimulating properties.
The Effects of α-Pyrrolidinopentiophenone
α-Pyrrolidinopentiophenone is a powerful stimulant substance with a variety of physiological effects. α-PVP causes an accelerated heart rate, raised blood pressure, reduced hunger, and euphoria. Additionally, the medicine has various adverse effects, including agitation, paranoia, hallucinations, and violence. In addition, the substance can be very addictive, and discontinuing it abruptly may result in withdrawal symptoms.
The Legal Status of α-Pyrrolidinopentiophenone
In the United States, α-Pyrrolidinopentiophenone is categorized as a Schedule I controlled substance, which makes its manufacturing, distribution, and possession unlawful. In several other nations, including the United Kingdom, Australia, and Canada, the medication is similarly categorized as a restricted substance. α-PVP is extensively available on the black market, where it is offered as a designer drug despite its categorization as a banned narcotic.
The Dangers of α-Pyrrolidinopentiophenone
α-Pyrrolidinopentiophenone is a highly toxic medication associated with various severe health consequences, including overdose and death. The substance has a significant potential for misuse, and those who use it are at risk for various mental and physical health issues, including addiction, depression, and cardiovascular disease. In addition, the medication may have long-term effects on the brain and neurological system, and continuous usage may result in cognitive and memory deficits.
To prepare the content, the following materials were used:
- FDA Substance Registration System
- Hazardous Substances Data Bank. National Library of Medicine. 28 August 2008. Retrieved 22 August 2014. 3,4-Methylenedioxymethamphetamine
- Liver transplant modulates gut microbial dysbiosis and cognitive function in cirrhosis. PDF . By HoChong Gilles, Scott C Matherly, Mohammed S Siddiqui, Puneet Puri...
- Differential impact of hyponatremia and hepatic encephalopathy on health-related quality of life and brain metabolite abnormalities in cirrhosis . By Jasmohan Bajaj
- An overview of alcohol and other drug issues
- Medicating the mind: a Kantian analysis of overprescribing psychoactive drugs B A Manninen
- The pharmacological basis of opioids Carla Ghelardini, Lorenzo Di Cesare Mannelli and Enrica Bianchi
- Ask Dr. Shulgin Online ARCHIVE: June 3, 2004
- Inhibition of plasma membrane monoamine transporters by β-ketoamphetamines. Nicholas V Cozzi, Michael KSievert, Alexander T Shulgin, Peyton JacobIII, Arnold Eruoho
- Schedules of Controlled Substances: Placement of Methylone Into Schedule I
- Bioanalysis of new designer drugs. Wohlfarth A, Weinmann W.
- New Psychoactive Substances (including synthetic cannabinoids, mephedrone, and more)
- Future Synthetic Drugs of Abuse. Donald A. Cooper. Drug Enforcement Administration McLean, Virginia
- Designer drugs: a medicinal chemistry perspective. F. Ivy Carroll Anita H. Lewin S. Wayne Mascarella Herbert H. Seltzman P. Anantha Reddy
- Synthetic cannabinoids in Europe
- Pharmacological Effects of MDMA in Man. By Enno Freye
- Drug Use in Relation to Outcome of Mammography Screening. von Euler-Chelpin M, Wu W, Vejborg and Lynge E
- DEA Drug Scheduling
- Electrophysiological Effects of Trace Amines on Mesencephalic Dopaminergic Neurons.Ada Ledonne, Nicola Berretta, Alessandro Davoli, Giada Ricciardo Rizzo, Giorgio Bernardi and Nicola Biagio Mercuri
- Electrophysiological evidence for a reciprocal interaction between amphetamine and cocaine-related drugs on rat midbrain dopaminergic neurons.Scarponi M, Bernardi G, Mercuri NB.
- Overdose of Drugs for Attention-Deficit Hyperactivity Disorder: Clinical Presentation, Mechanisms of Toxicity, and Management. Henry A. Spiller, author Hannah L. Hays Alfred Aleguas.
- Dose-dependent effectiveness of wheel running to attenuate cocaine-seeking: impact of sex and estrous cycle in rats. Peterson AB, Hivick DP, Lynch WJ.r.
- FDA Drug Safety Communication: Safety Review Update of Medications used to treat Attention-Deficit/Hyperactivity Disorder (ADHD) in children and young adults
- ADHD Medications and Risk of Serious Cardiovascular Events in Young and Middle-aged Adults
- Controlled Substances Act
- The Art of Drug Synthesis (Wiley Series on Drug Synthesis)
- Cannabis: domestic cultivation widespread
- A review of the influence of functional group modifications to the core scaffold of synthetic cathinones on drug pharmacokinetics
300g $970
500g $1300
300g $970
1kg $1690
100g $840
100mg $840
1kg $2400
500g $1080
200g $690
100g $600
1kg $1690